GZBL(SZ:002424) Shang Hai Zheng Quan Bao·2025-10-24 18:47Core Viewpoint - The company, Guizhou BaiLing Pharmaceutical Group Co., Ltd., has released its third-quarter report for 2025, ensuring the accuracy and completeness of the financial information disclosed [2][9][17]. Financial Data - The third-quarter financial report has not been audited [3][6]. - There are no adjustments or restatements of previous accounting data required [3]. - The company does not have any non-recurring profit and loss items applicable for this quarter [3]. Shareholder Information - The report includes details on the total number of ordinary shareholders and the top ten shareholders' holdings [5]. - There are no changes in the share lending situation of the top ten shareholders compared to the previous period [5]. Board and Supervisory Meetings - The sixth board of directors held its 20th meeting on October 24, 2025, where the third-quarter report was approved unanimously [9][10]. - The sixth supervisory board held its 12th meeting on the same day, also approving the third-quarter report with full attendance [17][19].